OneSource Specialty Pharma informs about press release

10 Apr 2025 Evaluate

OneSource Specialty Pharma has informed that it enclosed a press release made by the Company with respect to Good Manufacturing Practices (GMP) certification by ANVISA, the Brazilian Health Regulatory Agency, for OneSource flagship Unit 2 facility, following a successful regulatory inspection from November 18, 2024 to November 22, 2024. The above information is also available on the website of the Company: https://www.onesourcecdmo.com/investorrelations/stock-exchange-intimation/.

The above information is a part of company’s filings submitted to BSE.

Onesource Specialty Share Price

1741.95 17.00 (0.99%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×